| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.28 | 0.3 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |